Product Program year 2020 Source: CMS Open Payments

Mk-8591

Drug Infectious Disease

Open in the dashboard

General payments

$22,037

102 payments

Research payments

$5,817,929

977 payments

Through program year 2020, $22,037 in general payments and $5,817,929 in research payments were reported against Mk-8591 (Infectious Disease).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $7,923 12
2020 Research $4,687,865 532
2019 General $14,115 90
2019 Research $1,130,064 445

Breakdown

Who paid General payments · program years 2019–2020
  1. Merck Sharp & Dohme Corporation $22,037 102 payments
Top recipients General payments · program year 2020
  1. Raphael Landovitz Infectious Disease · Los Angeles, CA $2,250 28% · 4 payments
  2. Grace McComsey Infectious Disease · Cleveland, OH $1,225 15% · 1 payment
  3. Joseph Eron Infectious Disease · Chapel Hill, NC $1,225 15% · 1 payment
  4. Judith Aberg Infectious Disease · New York, NY $1,225 15% · 1 payment
  5. Heidi Crane Infectious Disease · Seattle, WA $1,125 14% · 1 payment

The top 5 of 7 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Infectious Disease Internal Medicine $7,050 90% · 5 practitioners
  2. Internal Medicine $750 10% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. California $3,000 38% · 2 recipients
  2. New York $1,225 15% · 1 recipient
  3. North Carolina $1,225 15% · 1 recipient
  4. Ohio $1,225 15% · 1 recipient
  5. Washington $1,125 14% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

102 general · 977 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record